5 relations: Antibody-drug conjugate, Cancer, Doxorubicin, Lewis antigen system, Seattle Genetics.
Antibody-drug conjugate
Antibody-drug conjugates or ADCs are an important class of highly potent biopharmaceutical drugs designed as a targeted therapy for the treatment of people with cancer.
New!!: CBR96-doxorubicin immunoconjugate and Antibody-drug conjugate · See more »
Cancer
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
New!!: CBR96-doxorubicin immunoconjugate and Cancer · See more »
Doxorubicin
Doxorubicin, sold under the trade names Adriamycin among others, is a chemotherapy medication used to treat cancer.
New!!: CBR96-doxorubicin immunoconjugate and Doxorubicin · See more »
Lewis antigen system
The Lewis antigen system is a human blood group system based upon genes on chromosome 19 p13.3 (FUT3 or Lewis gene) and 19q13.3, (FUT2 or secretor gene).
New!!: CBR96-doxorubicin immunoconjugate and Lewis antigen system · See more »
Seattle Genetics
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.
New!!: CBR96-doxorubicin immunoconjugate and Seattle Genetics · See more »
References
[1] https://en.wikipedia.org/wiki/CBR96-doxorubicin_immunoconjugate